Chines, E.; Vertillo Aluisio, G.; Mezzatesta, M.L.; Santagati, M.; Cafiso, V.
Mutation- and Transcription-Driven Omic Burden of Daptomycin/Dalbavancin-R and Glycopeptide-RS Fitness Costs in High-Risk MRSA: A Nexus in Antimicrobial Resistance Mechanisms—Genome Proneness—Compensatory Adaptations. Antibiotics 2025, 14, 465.
https://doi.org/10.3390/antibiotics14050465
AMA Style
Chines E, Vertillo Aluisio G, Mezzatesta ML, Santagati M, Cafiso V.
Mutation- and Transcription-Driven Omic Burden of Daptomycin/Dalbavancin-R and Glycopeptide-RS Fitness Costs in High-Risk MRSA: A Nexus in Antimicrobial Resistance Mechanisms—Genome Proneness—Compensatory Adaptations. Antibiotics. 2025; 14(5):465.
https://doi.org/10.3390/antibiotics14050465
Chicago/Turabian Style
Chines, Eleonora, Gaia Vertillo Aluisio, Maria Lina Mezzatesta, Maria Santagati, and Viviana Cafiso.
2025. "Mutation- and Transcription-Driven Omic Burden of Daptomycin/Dalbavancin-R and Glycopeptide-RS Fitness Costs in High-Risk MRSA: A Nexus in Antimicrobial Resistance Mechanisms—Genome Proneness—Compensatory Adaptations" Antibiotics 14, no. 5: 465.
https://doi.org/10.3390/antibiotics14050465
APA Style
Chines, E., Vertillo Aluisio, G., Mezzatesta, M. L., Santagati, M., & Cafiso, V.
(2025). Mutation- and Transcription-Driven Omic Burden of Daptomycin/Dalbavancin-R and Glycopeptide-RS Fitness Costs in High-Risk MRSA: A Nexus in Antimicrobial Resistance Mechanisms—Genome Proneness—Compensatory Adaptations. Antibiotics, 14(5), 465.
https://doi.org/10.3390/antibiotics14050465
